Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines

Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines

Aim: Combined use of herbal medicines in patients underwent dual antiplatelet therapy (DAPT) might cause bleeding or thrombosis because herbal medicines with anti-platelet activities may exhibit interactions with DAPT. In this study, we tried to use a feedback system control (FSC) optimization techn...

Full description

Bibliographic Details
Main Authors:	Wang Liu, Yu-Long Li, Mu-Ting Feng, Yu-Wei Zhao, Xianting Ding, Ben He, Xuan Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-05-01
Series:	Frontiers in Physiology
Subjects:	feedback system control dual antiplatelet therapy herbal medicine platelet aggregation optimization synergism
Online Access:	http://journal.frontiersin.org/article/10.3389/fphys.2018.00491/full

Similar Items

Clinical evaluation of role of dual antiplatelet therapy on bleeding after dental extraction
by: Prashant Babaji, et al.
Published: (2018-01-01)

Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy
by: GianMarco Podda, et al.
Published: (2018-10-01)

Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study
by: Joanna Sikora, et al.
Published: (2024-02-01)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram ® Platelet Mapping™
by: Kenneth N Hiller
Published: (2016-01-01)

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
by: Borges JMDM, et al.
Published: (2018-10-01)

Effect of antiplatelet agents on Escherichia coli sepsis mechanisms: A review
by: Antoine Mariotti, et al.
Published: (2022-12-01)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
by: Nadji Hannachi, et al.
Published: (2020-06-01)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
by: Yinping Guo, et al.
Published: (2021-11-01)

Protease‐activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model
by: Jess Berry, et al.
Published: (2022-03-01)

Antiplatelet agents: an overview
by: Asma Haffouz, et al.
Published: (2023-01-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
by: Yuji Shimada, et al.
Published: (2022-09-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01)

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy
by: Bernadeta Chyrchel, et al.
Published: (2023-07-01)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
by: Mei-Tzu Wang, et al.
Published: (2018-11-01)

ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
by: K. Yu. Lukianets, et al.
Published: (2020-10-01)

Panax quinquefolius saponins combined with dual antiplatelet therapy enhanced platelet inhibition with alleviated gastric injury via regulating eicosanoids metabolism
by: Wenting Wang, et al.
Published: (2023-08-01)

Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice
by: L I Buryachkovskaya, et al.
Published: (2009-05-01)

Steam-cooking rapidly destroys and reverses onion-induced antiplatelet activity
by: Hansen Emilie A, et al.
Published: (2012-09-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Absence of bleeding upon dual antiplatelet therapy in a patient with a immune GPVI deficiency
by: Stéphane Loyau Inserm, et al.
Published: (2021-07-01)

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
by: Ma Y, et al.
Published: (2018-05-01)

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
by: Yingqiu Liu, et al.
Published: (2018-11-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting
by: Chaobo Bai, et al.
Published: (2022-06-01)

Identification of Potential Drug Targets for Antiplatelet Therapy Specifically Targeting Platelets of Old Individuals through Proteomic Analysis
by: Seung Hee Lee, et al.
Published: (2023-10-01)

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
by: Fan ZG, et al.
Published: (2016-10-01)

Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring
by: Grzegorz Procyk, et al.
Published: (2022-03-01)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
by: Anne Godier, et al.
Published: (2020-07-01)

Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy
by: Kimitoshi Saito, et al.
Published: (2017-07-01)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
by: Ah Young Yoo, et al.
Published: (2023-11-01)

Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
by: Clara Bonanad, et al.
Published: (2022-03-01)